M1 muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/scisignal.abm3720
PubMed Identifier: 36378750
Publication URI: http://europepmc.org/abstract/MED/36378750
Type: Journal Article/Review
Volume: 15
Parent Publication: Science signaling
Issue: 760
ISSN: 1945-0877